Humana, Inc. Hits New 52-Week High at $390.02, Showcasing Strong Growth

Humana, Inc., a prominent player in the healthcare services industry, has reached a significant milestone by hitting a new 52-week high of USD 390.02 on June 29, 2026. This achievement reflects the company's robust performance over the past year, with a notable increase of 11.32%, although it trails behind the S&P 500's performance of 20.53% during the same period. With a market capitalization of USD 32,156 million, Humana operates within the large-cap segment of the market. The company's price-to-earnings (P/E) ratio stands at 27.00, indicating its valuation relative to earnings. Additionally, Humana offers a dividend yield of 1.60%, providing a return to its shareholders. The company's financial health is further illustrated by a debt-to-equity ratio of -0.42 and a return on equity of 6.81%. The stock's previous 52-week low was recorded at USD 163.11, highlighting the significant upward movement in its price. This new high marks a pivotal moment for Humana, showcasing its resilience and positioning within the competitive healthcare services landscape.